You don’t have products yet

View Products

Anti-CD4 for Tonsil Tumor Diagnosis

BioGenex presents Anti-CD4 antibody for Tonsil tumor diagnosis. CD4 is a 55-60 kD cell-surface glycoprotein, which participates in the molecular complexes involved in both T cell development and its antigen recognizing activity, by binding to the nonpolymorphic region of class II MHC. 
CD4 is considered as a stage marker of T cell development in the thymus, for it is expressed on the cell surface in a stage specific manner, during T cell development. This antibody reacts on a low level with human monocytes and macrophages but does not react with B-cells , granulocytes and thrombocytes
BioGenex offers ready-to-use (RTU) & concentrated forms of antibodies for both manual & automated systems which are best-in-class for clinicopathological diagnosis & drug discovery. It enables pathologists & clinicians to precisely diagnose and improve life expectancy.

If you have any queries regarding this antibody, please complete the form below.